Chorioamnionitis, an infection of the membranes surrounding the baby during pregnancy, affects roughly 4 in every 100 pregnancies worldwide. That 4.1% global average masks a wide range, though. Reported rates span from as low as 0.6% to nearly 20%, depending on the country, the hospital, and how the condition is diagnosed.
Overall Incidence
The most reliable global estimate comes from a meta-analysis that pooled data across multiple countries and arrived at a 4.1% incidence of clinically diagnosed chorioamnionitis. In high-resource settings, the number tends to be lower. A large U.S. study of approximately 9 million term births found a rate of 1.29%. That gap between the global average and U.S. figure reflects both genuine differences in risk factors and significant under-reporting in lower-resource countries, where diagnostic tools and documentation practices vary widely.
These numbers only capture cases where a clinician made a diagnosis during labor, typically based on maternal fever plus other signs like a fast fetal heart rate or uterine tenderness. Many infections are subclinical, meaning they cause inflammation in the placental membranes without producing obvious symptoms. When pathologists examine placental tissue under a microscope after delivery, they find evidence of inflammation far more often than clinical diagnosis alone would suggest.
Preterm Births Carry Much Higher Rates
Chorioamnionitis is dramatically more common in preterm deliveries. One study comparing cesarean deliveries at term versus preterm found acute chorioamnionitis on tissue examination in 49.2% of preterm cases, compared to just 7.9% of term cases. Moderate inflammation showed a similar pattern: 14.3% of preterm placentas versus 3.2% of term placentas. Severe chorioamnionitis appeared exclusively in the preterm group at 4.8%.
This isn’t a coincidence. In many preterm births, an undetected infection is what triggers early labor in the first place. The inflammation weakens the membranes and stimulates contractions. So the relationship runs in both directions: chorioamnionitis causes preterm birth, and preterm birth populations contain far more cases of chorioamnionitis.
Why Diagnosis Criteria Change the Numbers
How you define the condition significantly changes how common it appears. In 2017, the American College of Obstetricians and Gynecologists introduced updated classification criteria that broadened the definition beyond the older “clinical chorioamnionitis” label. One study comparing the different diagnostic frameworks in the same patient population found that the classic definition identified 24.4% of laboring women as having the infection, while the newer criteria flagged 38.9%. That’s a roughly 60% increase in diagnosed cases, not because the infection became more common, but because the diagnostic net widened.
This matters if you’re comparing numbers across different time periods or hospitals. A rate from 2010 and a rate from 2020 may not be measuring the same thing.
What Causes It
The infection is usually polymicrobial, meaning multiple types of bacteria are involved rather than a single culprit. These bacteria typically originate from the normal vaginal flora and ascend through the cervix into the uterine cavity. In rare cases, the infection reaches the amniotic fluid through invasive procedures like amniocentesis, or spreads through the bloodstream from an infection elsewhere in the body.
Several factors increase the risk. Being pregnant for the first time, having your water broken for an extended period, undergoing multiple cervical exams during labor, and having internal fetal monitors placed all raise the odds. Carrying group B strep or certain sexually transmitted infections also increases susceptibility. Meconium-stained amniotic fluid (when the baby passes stool before birth) is another recognized risk factor.
Risks to the Baby
The primary concern for newborns is early-onset sepsis, a bloodstream infection in the first few days of life. The actual rate, while elevated compared to unexposed infants, is lower than many parents fear. Among infants born to mothers with chorioamnionitis, 0.7% developed culture-proven early-onset sepsis. That compares to 0.1% when chorioamnionitis was not present. So the risk is roughly seven times higher in relative terms, but still affects fewer than 1 in 100 exposed babies in absolute terms.
Breathing problems are also more common. Exposure to chorioamnionitis roughly triples the odds of respiratory distress after birth. The suspected (but not yet confirmed) sepsis rate is also about four times higher in these newborns, which is why hospitals typically monitor exposed infants more closely and may start precautionary treatment while waiting for test results.
Risks to the Mother
For the mother, chorioamnionitis affects the uterus’s ability to contract effectively after delivery. This can lead to labor that stalls or progresses slowly, and it raises the risk of postpartum hemorrhage because the uterus doesn’t clamp down on bleeding vessels the way it normally would. Beyond bleeding, the infection can lead to a cascade of complications: wound infections after cesarean delivery, endometritis (infection of the uterine lining in the postpartum period), pelvic abscess, blood clots in the pelvic veins, and in serious cases, sepsis requiring intensive care. Unplanned hysterectomy and blood transfusion are rare but documented outcomes.
Most women with chorioamnionitis respond well to antibiotics given during labor and recover without lasting complications. The serious outcomes listed above represent the tail end of the risk spectrum, not the typical experience.